Henry Schein HSIC NASDAQ · Healthcare · United States
$84.96 -1.46% -$1.26
Summary
50 / 100 · Bulios Score
What speaks for it
- It bought back its own shares for $850.0M in the last fiscal year, 9.1% of its market value.
- It has been profitable 6 years in a row.
What to watch
- The share price is above the Bulios Fair Price.
- Earnings per share fell by 5.8% a year over the last 3 years.
- Out of every 100 USD of revenue, only 3.1 USD is left as net profit.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBy our assumptions the business is worth less than its shares cost today.
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 22.3 USD for 1 USD of yearly profit. Over the last five years it was 21.7 USD on average.
Valuation in detailIs it growing?
It is shrinkingRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 5.4% a year over 5 years. Over the last 3 years it grew by 1.4% a year. For the next fiscal year analysts expect revenue to grow by 2.7%. Earnings per share fell by 5.8% a year over the last 3 years.
Growth in detailDoes it make money?
PoorlyWhere 100 USD of revenue goes
- Cost of sales 69 USD
- Sales and administration 25 USD
- Taxes and other 2.6 USD
- Net profit 3.1 USD
Net profit, industry median (Medical - Distribution) 1.4 USD
Out of every 100 USD of revenue, 3.1 USD is left as net profit.
Profitability in detailIs it financially healthy?
Debt is a burdenRepaying all its debt would take 7.4 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 17
- Hold 14
- Sell 3
Today's price within the analysts' price targets
The average target of $97.14 is 14% above today's price. 50% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2018By product
- Healthcare Distribution 96%
- Technology 3.9%
By region
- UNITED STATES 100%
Healthcare Distribution brings in 96% of revenue. Technology grew fastest, by 9.7% a year.
Segments in detail